Literature DB >> 10942861

Canadian Acute Respiratory Illness and Flu Scale (CARIFS): development of a valid measure for childhood respiratory infections.

B Jacobs1, N L Young, P T Dick, M M Ipp, R Dutkowski, H D Davies, J M Langley, S Greenberg, D Stephens, E E Wang.   

Abstract

Although acute respiratory infection (ARI) is the most frequent clinical syndrome in childhood, there is no validated measure of its severity. Therefore a parental questionnaire was developed: the Canadian Acute Respiratory Illness Flu Scale (CARIFS). A process of item generation, item reduction, and scale construction resulted in a scale composed of 18 items covering three domains; symptoms (e.g., cough); function (e.g., play), and parental impact (e.g., clinginess). The validity of the scale was evaluated in a study of 220 children with ARI. Construct validity was assessed by comparing the CARIFS score with physician, nurse, and parental assessment of the child's health. Data were available from 206 children (94%). The CARIFS correlated well with measures of the construct (Spearman's correlations between 0.36 and 0.52). Responsiveness was shown, with 90% of children having a CARIFS score less than a quarter of its initial value, by the tenth day.

Entities:  

Mesh:

Year:  2000        PMID: 10942861     DOI: 10.1016/s0895-4356(99)00238-3

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  39 in total

1.  Clinical course of acute infection of the upper respiratory tract in children: cohort study.

Authors:  Christopher C Butler; Paul Kinnersley; Kerenza Hood; Mike Robling; Hayley Prout; Stephen Rollnick; Helen Houston
Journal:  BMJ       Date:  2003-11-08

2.  Office-based research: A new era and new opportunities.

Authors:  Moshe Ipp
Journal:  Paediatr Child Health       Date:  2002-09       Impact factor: 2.253

3.  Better drug therapy for children: Time for action.

Authors:  Michael J Rieder
Journal:  Paediatr Child Health       Date:  2003-04       Impact factor: 2.253

4.  Role of short-term use of L. acidophilus DDS-1 and B. lactis UABLA-12 in acute respiratory infections in children: a randomized controlled trial.

Authors:  S V Gerasimov; V A Ivantsiv; L M Bobryk; O O Tsitsura; L P Dedyshin; N V Guta; B V Yandyo
Journal:  Eur J Clin Nutr       Date:  2015-10-14       Impact factor: 4.016

Review 5.  Oral Astragalus (Huang qi) for preventing frequent episodes of acute respiratory tract infection in children.

Authors:  Guobin Su; Xiankun Chen; Zhuangzhu Liu; Lihong Yang; Cecilia Stålsby Lundborg; Zehuai Wen; Xinfeng Guo; Xindong Qin; Jueyao Liang; Xusheng Liu
Journal:  Cochrane Database Syst Rev       Date:  2016-12-01

Review 6.  Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials.

Authors:  Matthew Shun-Shin; Matthew Thompson; Carl Heneghan; Rafael Perera; Anthony Harnden; David Mant
Journal:  BMJ       Date:  2009-08-10

7.  Parents' responses to symptoms of respiratory tract infection in their children.

Authors:  Norman R Saunders; Olwen Tennis; Sheila Jacobson; Marvin Gans; Paul T Dick
Journal:  CMAJ       Date:  2003-01-07       Impact factor: 8.262

8.  Effect of High-Dose vs Standard-Dose Wintertime Vitamin D Supplementation on Viral Upper Respiratory Tract Infections in Young Healthy Children.

Authors:  Mary Aglipay; Catherine S Birken; Patricia C Parkin; Mark B Loeb; Kevin Thorpe; Yang Chen; Andreas Laupacis; Muhammad Mamdani; Colin Macarthur; Jeffrey S Hoch; Tony Mazzulli; Jonathon L Maguire
Journal:  JAMA       Date:  2017-07-18       Impact factor: 56.272

9.  Validation of a short form Wisconsin Upper Respiratory Symptom Survey (WURSS-21).

Authors:  Bruce Barrett; Roger L Brown; Marlon P Mundt; Gay R Thomas; Shari K Barlow; Alex D Highstrom; Mozhdeh Bahrainian
Journal:  Health Qual Life Outcomes       Date:  2009-08-12       Impact factor: 3.186

10.  Respiratory infections for which general practitioners consider prescribing an antibiotic: a prospective study.

Authors:  Anthony Harnden; Rafael Perera; Angela B Brueggemann; Richard Mayon-White; Derrick W Crook; Anne Thomson; David Mant
Journal:  Arch Dis Child       Date:  2007-03-16       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.